{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T09:57:21Z","timestamp":1794218241397,"version":"4.8.0"},"reference-count":43,"publisher":"BMJ","issue":"12","funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007602","name":"Programme Grants for Applied Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007602","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002284","name":"Asthma Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002284","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Thorax"],"published-print":{"date-parts":[[2018,12]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Asthma guidelines guide health practitioners to adjust treatments to the minimum level required for asthma control. As many people with asthma have an eosinophilic endotype, tailoring asthma medications based on airway eosinophilic levels (sputum eosinophils or exhaled nitric oxide, FeNO) may improve asthma outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To synthesise the evidence from our updated Cochrane systematic reviews, for tailoring asthma medication based on eosinophilic inflammatory markers (sputum analysis and FeNO) for improving asthma-related outcomes in children and adults.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Data sources<\/jats:title>\n                    <jats:p>Cochrane reviews with standardised searches up to February 2017.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Study selection<\/jats:title>\n                    <jats:p>The Cochrane reviews included randomised controlled comparisons of tailoring asthma medications based on sputum analysis or FeNO compared with controls (primarily clinical symptoms and\/or spirometry\/peak flow).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The 16 included studies of FeNO-based management (seven in adults) and 6 of sputum-based management (five in adults) were clinically heterogeneous. On follow-up, participants randomised to the sputum eosinophils strategy (compared with controls) were significantly less likely to have exacerbations (62 vs 82\/100 participants with \u22651\u2009exacerbation; OR 0.36, 95%\u2009CI 0.21 to 0.62). For the FeNO strategy, the respective numbers were adults OR 0.60 (95%\u2009CI 0.43 to 0.84) and children 0.58 (95% CI 0.45 to 0.75). However, there were no significant group differences for either strategy on daily inhaled corticosteroids dose (at end of study), asthma control or lung function.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Adjusting treatment based on airway eosinophilic markers reduced the likelihood of asthma exacerbations but had no significant impact on asthma control or lung function.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/thoraxjnl-2018-211540","type":"journal-article","created":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T12:21:04Z","timestamp":1527855664000},"page":"1110-1119","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":149,"title":["Tailoring asthma treatment on eosinophilic markers (exhaled nitric oxide or sputum eosinophils): a systematic review and meta-analysis"],"prefix":"10.1136","volume":"73","author":[{"given":"Helen L","family":"Petsky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris J","family":"Cates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayleigh M","family":"Kew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne B","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2018,6,1]]},"reference":[{"key":"2020050723423629000_73.12.1110.1","unstructured":"Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention. 2017 http:\/\/ginasthma.org\/2017-gina-report-global-strategy-for-asthma-management-and-prevention\/ (accessed Nov 2017)."},{"key":"2020050723423629000_73.12.1110.2","unstructured":"British Thoracic Society (BTS)\/Scottish Intercollegiate Guidelines Network (SIGN). British guideline on the management of asthma\u2014a national clinical guideline. 2016 https:\/\/www.brit-thoracic.org.uk\/document-library\/clinical-information\/asthma\/btssign-asthma-guideline-2016."},{"key":"2020050723423629000_73.12.1110.3","unstructured":"National Asthma Council, Australia. Asthma Management Handbook Melbourne. 2016 http:\/\/www.asthmahandbook.org.au (accessed July 2017)."},{"key":"2020050723423629000_73.12.1110.4","doi-asserted-by":"publisher","DOI":"10.1067\/mai.2001.112262"},{"key":"2020050723423629000_73.12.1110.5","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200801-060ST"},{"key":"2020050723423629000_73.12.1110.6","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200409-1242OC"},{"key":"2020050723423629000_73.12.1110.7","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s40259-017-0242-5","article-title":"Asthma phenotypes and endotypes: implications for personalised therapy","volume":"31","author":"Dean","year":"2017","journal-title":"BioDrugs"},{"key":"2020050723423629000_73.12.1110.8","doi-asserted-by":"publisher","DOI":"10.1136\/thorax.57.7.643"},{"key":"2020050723423629000_73.12.1110.9","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2006.073429"},{"key":"2020050723423629000_73.12.1110.10","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/BF03256635","article-title":"Clinical usefulness of inflammatory markers in asthma","volume":"2","author":"Wark","year":"2003","journal-title":"Am J Respir Med"},{"key":"2020050723423629000_73.12.1110.11","doi-asserted-by":"publisher","DOI":"10.1007\/s00424-002-0816-y"},{"key":"2020050723423629000_73.12.1110.12","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2010.135574"},{"key":"2020050723423629000_73.12.1110.13","first-page":"Cd011439","article-title":"Exhaled nitric oxide levels to guide treatment for children with asthma","volume":"11","author":"Petsky","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"2020050723423629000_73.12.1110.14","first-page":"Cd011440","article-title":"Exhaled nitric oxide levels to guide treatment for adults with asthma","volume":"9","author":"Petsky","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"2020050723423629000_73.12.1110.15","first-page":"CD005603","article-title":"Tailored interventions based on sputum eosinophils versus clinical symptoms for asthma in children and adults","volume":"8","author":"Petsky","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"2020050723423629000_73.12.1110.16","doi-asserted-by":"crossref","unstructured":"Rx V . Online NNT calculator [program]. 3 version, 2008.","DOI":"10.1016\/S1350-4789(08)70288-5"},{"key":"2020050723423629000_73.12.1110.17","unstructured":"In: Higgins JP , Green S , eds. Analysing and presenting results. Chichester, UK: John Wiley & Sons Ltd, updated, 2005."},{"key":"2020050723423629000_73.12.1110.18","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200503-458OC"},{"key":"2020050723423629000_73.12.1110.19","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.20455"},{"key":"2020050723423629000_73.12.1110.20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2010\/691425","article-title":"FeNO as a Marker of airways inflammation: the possible implications in childhood asthma management","volume":"2010","author":"Verini","year":"2010","journal-title":"J Allergy"},{"key":"2020050723423629000_73.12.1110.21","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa043596"},{"key":"2020050723423629000_73.12.1110.22","first-page":"334","article-title":"[A study on a therapeutic protocol to improve the control of persistent asthma by monitoring sputum eosinophil counts]","volume":"30","author":"Cao","year":"2007","journal-title":"Zhonghua Jie He He Hu Xi Za Zhi"},{"key":"2020050723423629000_73.12.1110.23","doi-asserted-by":"publisher","DOI":"10.1177\/147323000603400202"},{"key":"2020050723423629000_73.12.1110.24","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)11679-5"},{"key":"2020050723423629000_73.12.1110.25","doi-asserted-by":"publisher","DOI":"10.2174\/1871524915666150710123415"},{"key":"2020050723423629000_73.12.1110.26","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2010.156836"},{"key":"2020050723423629000_73.12.1110.27","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)60971-9"},{"key":"2020050723423629000_73.12.1110.28","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.23064"},{"key":"2020050723423629000_73.12.1110.29","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)61448-8"},{"key":"2020050723423629000_73.12.1110.30","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200807-1010OC"},{"key":"2020050723423629000_73.12.1110.31","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.06.00137704"},{"key":"2020050723423629000_73.12.1110.32","doi-asserted-by":"publisher","DOI":"10.1111\/j.1752-699X.2012.00306.x"},{"key":"2020050723423629000_73.12.1110.33","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2014-206161"},{"key":"2020050723423629000_73.12.1110.34","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.22873"},{"key":"2020050723423629000_73.12.1110.35","doi-asserted-by":"publisher","DOI":"10.1001\/2012.jama.10893"},{"key":"2020050723423629000_73.12.1110.36","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2010.153411"},{"key":"2020050723423629000_73.12.1110.37","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2014.07.016"},{"key":"2020050723423629000_73.12.1110.38","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200610-1427OC"},{"key":"2020050723423629000_73.12.1110.39","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.jaip.2013.07.013","article-title":"Anti-inflammatory treatment of atopic asthma guided by exhaled nitric oxide: a randomized, controlled trial","volume":"1","author":"Syk","year":"2013","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2020050723423629000_73.12.1110.40","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2005.01.031"},{"key":"2020050723423629000_73.12.1110.41","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.9120-11ST"},{"key":"2020050723423629000_73.12.1110.42","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200406-710ST"},{"key":"2020050723423629000_73.12.1110.43","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)60988-X"}],"container-title":["Thorax"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/thoraxjnl-2018-211540","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T02:06:02Z","timestamp":1601085962000},"score":1,"resource":{"primary":{"URL":"https:\/\/thorax.bmj.com\/lookup\/doi\/10.1136\/thoraxjnl-2018-211540"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,1]]},"references-count":43,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2018,11,14]]},"published-print":{"date-parts":[[2018,12]]}},"alternative-id":["10.1136\/thoraxjnl-2018-211540"],"URL":"https:\/\/doi.org\/10.1136\/thoraxjnl-2018-211540","relation":{},"ISSN":["0040-6376","1468-3296"],"issn-type":[{"value":"0040-6376","type":"print"},{"value":"1468-3296","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,1]]}}}